Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Aug 24;3(5929):499–501. doi: 10.1136/bmj.3.5929.499

Relapses after Withdrawal of Proguanil Treatment in Tropical Splenomegaly Syndrome

Aba S David-West
PMCID: PMC1611220  PMID: 4415529

Abstract

After the remission of symptoms and reduction in spleen size while on proguanil therapy four patients with the tropical splenomegaly syndrome defaulted from treatment. The withdrawal of proguanil caused a recrudescence of original symptoms, splenomegaly, and a return of the initially raised serum IgM. Complete return to normal values was again effected with proguanil therapy.

The role of the spleen in the tropical splenomegaly syndrome in the production of the raised serum IgM is discussed. These patients should be educated as to the nature of their disease and the importance of continued medical treatment.

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FAHEY J. L., MCKELVEY E. M. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol. 1965 Jan;94:84–90. [PubMed] [Google Scholar]
  2. Lowenthal M. N., O'Riordan E. C., Hutt M. S. Tropical splenomegaly syndrome in Zambia: further observations and effects of cycloguanil and proguanil. Br Med J. 1971 Feb 20;1(5746):429–432. doi: 10.1136/bmj.1.5746.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Peters W. A new type of antimalarial drug potentiation. Trans R Soc Trop Med Hyg. 1970;64(3):462–464. doi: 10.1016/0035-9203(70)90189-6. [DOI] [PubMed] [Google Scholar]
  4. Pryor D. S. Tropical splenomegaly in New Guinea. Q J Med. 1967 Jul;36(143):321–336. [PubMed] [Google Scholar]
  5. Richmond J., Donaldson G. W., Williams R., Hamilton P. J., Hutt M. S. Haematological effects of theidiopathic splenomegaly seen in Uganda. Br J Haematol. 1967 May;13(3):348–363. doi: 10.1111/j.1365-2141.1967.tb08750.x. [DOI] [PubMed] [Google Scholar]
  6. Sagoe A. S., Edington G. M. Histopathology of the spleen of patients with the tropical splenomegaly syndrome in Ibadan. West Afr Med J Niger Med Dent Pract. 1972 Dec;21(6):168–171. [PubMed] [Google Scholar]
  7. Sagoe A. S. Tropical splenomegaly syndrome: long-term proguanil therapy correlated with spleen size, serum IgM, and lymphocyte transformation. Br Med J. 1970 Aug 15;3(5719):378–382. doi: 10.1136/bmj.3.5719.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Stuiver P. C., Ziegler J. L., Wood J. B., Morrow R. H., Hutt M. S. Clinical trial of malaria prophylaxis in tropical splenomegaly syndrome. Br Med J. 1971 Feb 20;1(5746):426–429. doi: 10.1136/bmj.1.5746.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Watson-Williams E. J., Allan N. C. Idiopathic tropical splenomegaly syndrome in Ibadan. Br Med J. 1968 Dec 28;4(5634):793–796. doi: 10.1136/bmj.4.5634.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ziegler J. L., Cohen M. H., Hutt M. S. Immunological studies in tropical splenomegaly syndrome in Uganda. Br Med J. 1969 Oct 4;4(5674):15–17. doi: 10.1136/bmj.4.5674.15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES